Does 10g of creatine do something for your brain? What the latest research actually shows

For thirty years, the case for creatine has been a strength-and-power story. Three to five grams of creatine monohydrate a day, taken consistently, raises the phosphocreatine pool in skeletal muscle and produces a small but reliable bump in high-intensity output and lean-mass gain. That part of the literature is about as settled as nutrition science gets.

What is newer — and what has driven the recent press cycle — is a run of studies asking whether a noticeably bigger dose, usually 10 g a day or more, does anything for the brain. The short answer is: there is a real signal, it is stronger in some groups than others, and the doses that move the brain are not the ones on the back of most tubs.

Why the standard 5 g dose is a muscle dose

Creatine is a substrate for the phosphocreatine / ATP energy buffer that handles short bursts of high demand. Muscle takes it up readily from the blood via the CreaT1 transporter; saturating muscle stores takes about 3 g a day for roughly a month, or a 20 g/day loading week followed by 3–5 g maintenance.

The brain is a different problem. It has the same energy demand and uses the same buffer, but the blood-brain barrier and the cerebral creatine transporter make uptake from the blood much slower than in muscle. Magnetic resonance spectroscopy studies have repeatedly shown that the doses that comfortably saturate muscle do not reliably raise total brain creatine, or do so only modestly — on the order of a few per cent. Reviews of the brain-uptake literature land on a rough threshold: to see a meaningful rise in brain creatine, you typically need either about 20 g/day for 4–8 weeks, or somewhere in the 4–10 g/day range sustained for several months. Three grams a day is enough for the biceps and probably not enough for the cortex.

The Alzheimer’s pilot: a real 11% bump in brain creatine

The study that put high-dose creatine into the brain conversation most concretely is the CABA pilot trial (Creatine to Augment Bioenergetics in Alzheimer’s), led by Matthew Taylor at the University of Kansas and published in an Alzheimer’s Association journal in 2025. Nineteen participants aged 60–90 with Alzheimer’s disease took 20 g/day of creatine monohydrate for eight weeks.

• MR spectroscopy showed an 11% increase in brain creatine concentration over the eight weeks — meaningfully larger than what most earlier brain-uptake studies have managed to produce with smaller or shorter regimens.
• Participants showed measurable improvements in working memory and a near-statistically-significant improvement in executive function — both cognitive domains hit early in Alzheimer’s.
• The design is the standard caveat: a single-arm pilot with no placebo group, a small sample, and a short window. The investigators were explicit that the result motivates a larger randomised trial rather than a clinical recommendation.

What is genuinely interesting about CABA is not the cognitive score change — pilots like this routinely move scores in the right direction — but the brain-creatine measurement. It is one of the cleaner demonstrations that 20 g/day for two months actually does what the protocol is supposed to do at the tissue level.

Sleep deprivation: a single big dose, a measurable effect

A 2024 paper in Scientific Reports tested a one-off high dose — 0.35 g/kg, roughly 25 g for a 70 kg adult — in healthy participants kept awake for 21 hours and put through cognitive tests. The creatine group performed measurably better on processing speed and short-term memory than placebo, and MRS measurements suggested changes in cerebral high-energy phosphates consistent with the cognitive result.

The mechanism most often proposed for this kind of finding is not that creatine makes a rested brain smarter; it is that creatine buffers the energy cost of cognition under stress, and the gap shows up most clearly when the brain is energetically challenged — sleep loss, hypoxia, head injury, ageing pathology.

What 10 g/day does in healthy young adults: the honest answer is “not much, yet”

It would be tidy if 10 g/day produced a clean cognitive benefit in well-rested 25-year-olds, but the best controlled study to ask that question directly says it does not. A randomised dose-response trial by Forbes and Candow (Brain Sciences, 2023) randomised 30 healthy young adults to 10 g/day, 20 g/day, or placebo for six weeks and ran them through processing-speed, memory, and executive-function tests, plus fNIRS measures of prefrontal cortex activity.

• Neither the 10 g nor the 20 g group showed a significant cognitive benefit versus placebo.
• The authors did not measure brain creatine, so it is possible the supplementation simply did not raise it enough in this sample.
• A reasonable read is that healthy, well-rested young adults may already sit close to a cognitive ceiling on these tests, and the benefit of extra brain phosphocreatine only surfaces when the system is taxed.

Other recent work points in slightly different directions. A 2024 trial in Nutrients testing 10 g/day of creatine monohydrate alongside 2 g of guanidinoacetic acid (the immediate precursor to creatine) reported faster reaction time, better word recognition, and improved Stroop performance over six weeks. Systematic reviews and meta-analyses through 2024–2025 generally conclude the same thing: across the whole literature, the cognitive effect of creatine is small, inconsistent in healthy young adults, and most reliable in older adults, vegetarians (who have lower baseline stores), and people under metabolic stress.

What the evidence supports, and what it does not

Reading the recent papers as a whole, a careful summary looks like this:

• Muscle: 3–5 g/day of creatine monohydrate is well-established for strength, power, and lean-mass support. Going to 10 g a day for muscle alone buys you very little beyond faster saturation.
• Brain, healthy young adults: 10 g/day for six weeks does not reliably improve cognition in everyday conditions. Higher doses or longer durations may, but the controlled evidence is thin.
• Brain, under stress: there is a real signal for cognitive protection under sleep deprivation and related challenges, at single doses in the 0.3 g/kg range or sustained higher daily intake.
• Brain, older adults and clinical populations: the most clinically interesting signal so far — the CABA pilot in Alzheimer’s, plus several small trials in mild cognitive impairment and depression at 5–20 g/day — is enough to justify the larger randomised trials now in progress, not enough to treat anything.
• Safety: long-term studies at 5 g/day and shorter studies at 20 g/day have not produced the kidney or liver problems the early scare stories worried about, in healthy people. Existing renal disease is the obvious medical exception. The most common practical side-effect of higher doses is GI upset, usually mitigated by splitting the dose across the day.

If you are taking a higher dose, the certification question matters more

Creatine monohydrate is one of the easier supplement categories to manufacture well — the molecule is simple, the assay is straightforward, and the main quality marker (CreapureⓇ from AlzChem, for instance) refers to a specific German-made raw material with a documented impurity profile. It is also a category where independent testing has occasionally found products contaminated with things you would not want in a scoop, including small amounts of dihydrotriazines and other synthesis by-products.

Two practical points. First, dose: if you are scaling from 3 g to 10 g a day, you are tripling whatever else is in the powder along with the creatine. Independent batch testing is more useful, not less, at higher intake. Second, if you compete in any sport with anti-doping testing, creatine is not a banned substance but powders are a common source of inadvertent contamination with substances that are.

The third-party programmes that map cleanly onto creatine powders are Informed Sport and NSF Certified for Sport. Both screen every certified batch against the WADA-aligned banned-substance list and audit the manufacturing site; Informed Sport is the more common mark on UK-distributed creatine.

Practical takeaway

If you take creatine for the gym, 3–5 g a day is still the right answer and the research has not changed that. If you are interested in the brain side, the honest read of the current evidence is that the most consistent signals are at doses around 10 g a day or higher, sustained for weeks to months, and the people most likely to feel a difference are those under metabolic stress, vegetarians, and older adults — not well-rested young people whose cognition is already near its baseline ceiling.

Whatever dose you settle on, the higher you go, the more it matters that the powder in the tub is the molecule on the label and nothing else. A batch-tested certification is the cheapest way to find out before you start scooping.

You can browse all creatine products on Certwell — or filter by Informed Sport or NSF Certified for Sport — and read the longer reference on how each certification compares.